Designed for men and women who are dependent on opiate based drugs and medications, MRODS' rapid detox program
provides the highest quality services in the safe and confidential medical setting of an acute care medical center.
Prospective patients are given a comprehensive psychological and physical screening which includes EKG, chest x-rays, urinalysis, and
complete blood workup. A board certified internist then reviews the results and addresses all issues including the legitimate use of
pain and psychiatric medications that a prospective patient might be taking.
The potential benefits of a continuing care program after the rapid detox procedure are also weighed to ensure the best possible outcome for the patient.
Upon meeting the proper criteria, the patient is admitted late in the afternoon into a private room of our accredited (JCAHO -- Joint
Commission on Accreditation of Healthcare Organizations) acute care medical center. Here the patient begins to undergo the
pre-procedure process, and is monitored by our medical staff.
Family members and / or significant others are encouraged to be a part of the process as well and are welcome to be with the patient
throughout the patient's stay.
The morning after being admitted, the patient is brought to the rapid detox procedure area where he or she is fully sedated,
and the Anesthesia Assisted
Rapid Opiate Detoxification™ process is completed. The complete procedure usually lasts
from 4 - 6 hours.
The patient is discharged the following morning after the AAROD procedure and ongoing recovery commences. MRODS recognizes that
detoxification is only the first step in recovery from opiate dependency. Upon completion of the AAROD phase of treatment and discharge
from hospitalization, the patient begins a continuing care program to assure continuing recovery.
Depending on the patients individual needs this may include the following:
MRODS has a local and national network of approved providers which meets the most stringent criteria for excellence in
addiction and pain medicine. MRODS provides follow-up and support for one year after discharge. The patient also begins a
six-month regimen with an FDA approved non addicting relapse prevention drug taken daily orally or as a Naltrexone injection implant,
which is replaced every two months.
top ::
